MORGAN STANLEY - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$13,000,089
-23.2%
1,387,416
+101.2%
0.00%
-50.0%
Q2 2023$16,918,980
+21.4%
689,726
+15.2%
0.00%
+100.0%
Q1 2023$13,935,426
-53.3%
598,858
-49.2%
0.00%
-66.7%
Q4 2022$29,810,825
+35.0%
1,177,828
+2.8%
0.00%0.0%
Q3 2022$22,088,000
-19.8%
1,145,658
+5.9%
0.00%
-25.0%
Q2 2022$27,544,000
+81.0%
1,081,374
+82.8%
0.00%
+100.0%
Q1 2022$15,218,000
-70.5%
591,678
-51.9%
0.00%
-66.7%
Q4 2021$51,546,000
+719.4%
1,231,094
+751.6%
0.01%
+500.0%
Q3 2021$6,291,000
-60.8%
144,570
-57.4%
0.00%
-50.0%
Q2 2021$16,038,000
-22.3%
339,217
-15.8%
0.00%
-33.3%
Q1 2021$20,643,000
+717.2%
402,641
+326.8%
0.00%
Q4 2020$2,526,000
+80.3%
94,334
+131.2%
0.00%
Q3 2020$1,401,000
+20.2%
40,809
+43.4%
0.00%
Q2 2020$1,166,000
+85.1%
28,459
+54.8%
0.00%
Q1 2020$630,000
+223.1%
18,386
+19.0%
0.00%
Q4 2019$195,00015,4520.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders